State of Wisconsin Investment Board’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-82,300
Closed -$11.2M 2038
2020
Q3
$11.2M Buy
82,300
+1,800
+2% +$191K 0.03% 591
2020
Q2
$7.78M Buy
80,500
+9,700
+14% +$809K 0.02% 700
2020
Q1
$3.32M Buy
70,800
+4,100
+6% +$263K 0.01% 925
2019
Q4
$4.86M Hold
66,700
0.01% 944
2019
Q3
$3.48M Buy
66,700
+17,300
+35% +$920K 0.01% 902
2019
Q2
$2.48M Buy
49,400
+3,800
+8% +$185K 0.01% 984
2019
Q1
$2.37M Buy
45,600
+10,500
+30% +$484K 0.01% 971
2018
Q4
$1.72M Buy
35,100
+4,000
+13% +$220K 0.01% 1001
2018
Q3
$2.03M Hold
31,100
0.01% 1041
2018
Q2
$1.54M Buy
31,100
+11,100
+56% +$537K ﹤0.01% 1041
2018
Q1
$976K Buy
20,000
+8,000
+67% +$416K ﹤0.01% 1143
2017
Q4
$505K Hold
12,000
﹤0.01% 1292
2017
Q3
$514K Hold
12,000
﹤0.01% 1289
2017
Q2
$157K Buy
+12,000
New +$158K ﹤0.01% 1417

State of Wisconsin Investment Board's MYOK Position: Q4 2020 in Review

State of Wisconsin Investment Board sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 82,300 shares — an estimated $11.2M sold.

State of Wisconsin Investment Board first reported a position in MYOK in Q2 2017 and held it in 14 quarters. The position peaked at $11.2M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • State of Wisconsin Investment Board reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 82,300 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $11.2M.
  • State of Wisconsin Investment Board first reported a position in MyoKardia, Inc. Common Stock in Q2 2017 and held it in 14 quarters.
  • State of Wisconsin Investment Board's MyoKardia, Inc. Common Stock position peaked at $11.2M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2020, filed 3 Feb 2021.